High-Density Lipoprotein Vascular Protective Effects, Dysfunction, and Potential as Therapeutic Target

被引:228
作者
Luescher, Thomas F. [1 ,3 ]
Landmesser, Ulf [1 ,3 ]
von Eckardstein, Arnold [2 ]
Fogelman, Alan M. [4 ]
机构
[1] Univ Zurich Hosp, Dept Cardiol, Univ Heart Ctr, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Clin Chem, CH-8091 Zurich, Switzerland
[3] Univ Zurich, Inst Physiol, Div Cardiovasc Res, Zurich, Switzerland
[4] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA
基金
新加坡国家研究基金会; 美国国家卫生研究院;
关键词
apolipoprotein A-I; cholesterol; HDL; nitric oxide; REVERSE CHOLESTEROL TRANSPORT; APOLIPOPROTEIN-A-I; CORONARY-HEART-DISEASE; RANDOMIZED CONTROLLED-TRIAL; NITRIC-OXIDE SYNTHASE; B TYPE-I; BINDING CASSETTE TRANSPORTER; TYPE-2; DIABETES-MELLITUS; ENDOTHELIAL NO SYNTHASE; ESTER TRANSFER PROTEIN;
D O I
10.1161/CIRCRESAHA.114.300935
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High-density lipoprotein (HDL) is a complex mixture of lipoproteins that is associated with many minor proteins and lipids that influence the function of HDL. Although HDL is a promising marker and potential therapeutic target based on its epidemiological data and the effects of healthy HDL in vitro in endothelial cells and macrophages, as well as based on infusion studies of reconstituted HDL in patients with hypercholesterolemia, it remains still uncertain whether or not HDL cholesterol-raising drugs will improve outcomes. Recent studies suggest that HDL becomes modified in patients with coronary artery disease or acute coronary syndrome because of oxidative processes that result in alterations in its proteome composition (proteome remodelling) leading to HDL dysfunction.
引用
收藏
页码:171 / 182
页数:12
相关论文
共 113 条
[61]   High-Density Lipoprotein and 4F Peptide Reduce Systemic Inflammation by Modulating Intestinal Oxidized Lipid Metabolism Novel Hypotheses and Review of Literature [J].
Navab, Mohamad ;
Reddy, Srinivasa T. ;
Van Lenten, Brian J. ;
Buga, Georgette M. ;
Hough, Greg ;
Wagner, Alan C. ;
Fogelman, Alan M. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (11) :2553-2560
[62]   D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice [J].
Navab, Mohamad ;
Reddy, Srinivasa T. ;
Anantharamaiah, G. M. ;
Hough, Greg ;
Buga, Georgette M. ;
Danciger, Jan ;
Fogelman, Alan M. .
JOURNAL OF LIPID RESEARCH, 2012, 53 (03) :437-445
[63]   Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally [J].
Navab, Mohamad ;
Reddy, Srinivasa T. ;
Anantharamaiah, G. M. ;
Imaizumi, Satoshi ;
Hough, Greg ;
Hama, Susan ;
Fogelman, Alan M. .
JOURNAL OF LIPID RESEARCH, 2011, 52 (06) :1200-1210
[64]   Structure and Function of HDL Mimetics [J].
Navab, Mohamad ;
Shechter, Ishaiahu ;
Anantharamaiah, G. M. ;
Reddy, Srinivasa T. ;
Van Lenten, Brian J. ;
Fogelman, Alan M. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (02) :164-168
[65]   Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits [J].
Nicholls, SJ ;
Dusting, GJ ;
Cutri, B ;
Bao, S ;
Drummond, GR ;
Rye, KA ;
Barter, PJ .
CIRCULATION, 2005, 111 (12) :1543-1550
[66]   Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial [J].
Nissen, SE ;
Tsunoda, T ;
Tuzcu, EM ;
Schoenhagen, P ;
Cooper, CJ ;
Yasin, M ;
Eaton, GM ;
Lauer, MA ;
Sheldon, WS ;
Grines, CL ;
Halpern, S ;
Crowe, T ;
Blankenship, JC ;
Kerensky, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (17) :2292-2300
[67]   Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes (vol 356, pg 2457, 2007) [J].
Nissen, Steven E. ;
Wolski, Kathy .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2457-2471
[68]   Effect of torcetrapib on the progression of coronary atherosclerosis [J].
Nissen, Steven E. ;
Tardif, Jean-Claude ;
Nicholls, Stephen J. ;
Revkin, James H. ;
Shear, Charles L. ;
Duggan, William T. ;
Ruzyllo, Witold ;
Bachinsky, William B. ;
Lasala, Gregory P. ;
Tuzcu, E. Murat .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13) :1304-1316
[69]   Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysophingolipids [J].
Nofer, JR ;
Levkau, B ;
Wolinska, I ;
Junker, R ;
Fobker, M ;
von Eckardstein, A ;
Seedorf, U ;
Assmann, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) :34480-34485
[70]   HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3 [J].
Nofer, JR ;
van der Giet, M ;
Tölle, M ;
Wolinska, I ;
Lipinski, KVW ;
Baba, HA ;
Tietge, UJ ;
Gödecke, A ;
Ishii, I ;
Kleuser, B ;
Schäfers, M ;
Fobker, M ;
Zidek, W ;
Assmann, G ;
Chun, J ;
Levkau, B .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (04) :569-581